Glaukos
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
GKOS Key Statistics
Stock Snapshot
As of today, Glaukos(GKOS) shares are valued at $144.42. The company's market cap stands at 8.48B, with a P/E ratio of -43.88.
On 2026-06-28, Glaukos(GKOS) stock traded between a low of $140.91 and a high of $144.99. Shares are currently priced at $144.42, which is +2.5% above the low and -0.4% below the high.
Glaukos(GKOS) shares are trading with a volume of 1.87M, against a daily average of 915.11K.
In the last year, Glaukos(GKOS) shares hit a 52-week high of $148.11 and a 52-week low of $73.16.
In the last year, Glaukos(GKOS) shares hit a 52-week high of $148.11 and a 52-week low of $73.16.
GKOS News
Glaukos Corporation recently completed patient enrollment in its Phase 2 U.S. clinical trial of GLK-321, a physostigmine-based cream using its iLution eyelid dr...
Glaukos (GKOS) announced completion of patient enrollment in its Phase 2 clinical study evaluating GLK-321 for the treatment of Demodex blepharitis. “Completion...
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.